Literature DB >> 23366584

An elementary analysis of physiologic shock and multi-organ failure: the autodigestion hypothesis.

Geert W Schmid-Schonbein1, Frank A DeLano, Alexander H Penn, Erik Kistler.   

Abstract

Physiological shock and subsequent multi-organ failure is one of the most important medical problems from a mortality point of view. No agreement exists for mechanisms that lead to the relative rapid cell and organ failure during this process and no effective treatment. We postulate that the digestive enzymes synthesized in the pancreas and transported in the lumen of the small intestine as requirement of normal food digestion play a central role in multi-organ failure. These powerful enzymes are usually compartmentalized in the lumen of the intestine by the mucosal barrier, but may escape into the wall of the intestine if the permeability of the mucosal lining increases. Entry of the digestive enzymes into the wall of the intestine precipitates an autodigestion process as well as an escape of pancreatic enzymes and breakdown products generated by them into the system circulation. The consequence of autodigestion is multiorgan failure. We discuss the possibility to block the digestive enzymes in acute forms of shock as a potential therapeutic intervention.

Entities:  

Mesh:

Year:  2012        PMID: 23366584     DOI: 10.1109/EMBC.2012.6346623

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

Review 1.  Redefining the gut as the motor of critical illness.

Authors:  Rohit Mittal; Craig M Coopersmith
Journal:  Trends Mol Med       Date:  2013-09-18       Impact factor: 11.951

Review 2.  Pathophysiology of the Gut and the Microbiome in the Host Response.

Authors:  John D Lyons; Craig M Coopersmith
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 3.  Interplay between Gut Lymphatic Vessels and Microbiota.

Authors:  Eleonora Solari; Cristiana Marcozzi; Daniela Negrini; Andrea Moriondo
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.